| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $60.24B | $42.50B | $51.58B |
| YoY Revenue Growth % | +41.7% | -17.6% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$284.8M | $409.1M | $269.6M |
| Operating Margin % | -0.5% | 1.0% | 0.5% |
| Net Income (GAAP) | -$241.3M | $346.7M | $228.5M |
| EBITDA (Normalized) | $1.88B | $1.94B | $2.13B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$316.6M | -$205.1M | -$4.1M |
| Capital Expenditures (CapEx) | $2.71B | $1.91B | $2.32B |
| Free Cash Flow (FCF) | -$3.03B | -$2.12B | -$2.33B |
| FCF Margin % | -5.0% | -5.0% | -4.5% |
| Return on Invested Capital (ROIC %) | -5.1% | 8.2% | 0.6% |
| Cash & Short-Term Equivalents | $1.25B | $462.1M | — |
| Total Debt (Short + Long Term) | $3.74B | $2.22B | $14.48B |
| Total Stockholders' Equity | $1.96B | $2.19B | $29.71B |